# Thiakis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thiakis

- Industry: Biotechnology
- Headquarters: London, UK
- Total disclosed funding: $18M
- Latest round: Series A (Aug 1, 2006)
- Investors on record: 5

## About

Founded in 2004, Thiakis Limited operates as a biopharmaceutical company. It develops medicines for the treatment of obesity, including type-two diabetes and cardiovascular diseases, and metabolic diseases.

## Funding rounds

- Series A, Aug 1, 2006, $18M — Life Science Venture Partners, Touchstone Innovations, Novo Holdings A/S, Royal Society Enterprise, Advent Life Sciences

## Investors

- Life Science Venture Partners — Series A
- Touchstone Innovations (https://capitalatlas.ai/funds/touchstone-innovations) — Series A
- Novo Holdings A/S — Series A
- Royal Society Enterprise — Series A
- Advent Life Sciences (https://capitalatlas.ai/funds/advent-life-sciences) — Series A